CANDESARTAN CILEXETIL

Product NDC
70518-2719
11-digit product format
705182719
Labeler code
70518
Product ID
70518-2719_d6e62933-ba53-7a51-e053-2a95a90a966a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
CANDESARTAN CILEXETIL
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA210302
Marketing category
ANDA
Marketing start
2020-05-01
Marketing end
0000-00-00
Substance
CANDESARTAN CILEXETIL
Active strength
16 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2719-02022-01-31C16284748780-1d6a99b39-47d0-a426-e053-dadaa90af4c28b2354fe-f507-4c57-926d-a26c4b88c0a2
70518-2719-02022-01-28C16284748780-1d6a99b39-47d0-a426-e053-dadaa90af4c28b2354fe-f507-4c57-926d-a26c4b88c0a2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2719-07051827190090 TABLET in 1 BOTTLE, PLASTIC (70518-2719-0) 90 tablet2020-05-010000-00-00NoNoCurrent